NINTH SUPPLEMENTAL INDENTURENinth Supplemental Indenture • June 12th, 2007 • Inverness Medical Innovations Inc • In vitro & in vivo diagnostic substances • New York
THIS NINTH SUPPLEMENTAL INDENTURE, dated as of June 12, 2007 (this “Ninth Supplemental Indenture”), to the Indenture (as defined below), is hereby entered into by and among Inverness Medical Innovations, Inc., a Delaware corporation (the “Issuer”), the Guarantors (as defined in the Indenture) and U.S. Bank Trust National Association (the “Trustee”).
